Abstract

ObjectivesMaternal infection during pregnancy increases risk of severe neuropsychiatric disorders, including schizophrenia and autism, in the offspring. The most consistent brain structural abnormality in patients with schizophrenia is enlarged lateral ventricles. However, it is unknown whether the aetiology of ventriculomegaly in schizophrenia involves prenatal infectious processes. The present experiments tested the hypothesis that there is a causal relationship between prenatal immune challenge and emergence of ventricular abnormalities relevant to schizophrenia in adulthood.MethodWe used an established mouse model of maternal immune activation (MIA) by the viral mimic PolyI:C administered in early (day 9) or late (day 17) gestation. Automated voxel-based morphometry mapped cerebrospinal fluid across the whole brain of adult offspring and the results were validated by manual region-of-interest tracing of the lateral ventricles. Parallel behavioral testing determined the existence of schizophrenia-related sensorimotor gating abnormalities.ResultsPolyI:C-induced immune activation, in early but not late gestation, caused marked enlargement of lateral ventricles in adulthood, without affecting total white and grey matter volumes. This early exposure disrupted sensorimotor gating, in the form of prepulse inhibition. Identical immune challenge in late gestation resulted in significant expansion of 4th ventricle volume but did not disrupt sensorimotor gating.ConclusionsOur results provide the first experimental evidence that prenatal immune activation is an environmental risk factor for adult ventricular enlargement relevant to schizophrenia. The data indicate immune-associated environmental insults targeting early foetal development may have more extensive neurodevelopmental impact than identical insults in late prenatal life.

Highlights

  • The aetiology of complex neurodevelopmental brain disorders such as schizophrenia and autism is unknown

  • The volumetric analyses of in-vivo magnetic resonance imaging (MRI) data showed that prenatal immune activation in early (GD9) or late (GD17) gestation did not significantly change total brain volume (F(2,19) = .162, p,.851), grey matter (F(2,19) = .017, p,.98) or white matter volume (F(2,19) = .136, p,.87) relative to prenatal control treatment

  • The application of voxelbased morphometry (VBM) to map the volume of cerebrospinal fluid (CSF) showed greater CSF volumes in the lateral ventricles of offspring exposed to maternal immune activation (MIA) on GD9 compared to control offspring (Figure 1)

Read more

Summary

Introduction

The aetiology of complex neurodevelopmental brain disorders such as schizophrenia and autism is unknown. Epidemiological evidence strongly suggests that maternal infection during prenatal life may contribute to an increased risk of schizophrenia or autism in the offspring [1,2,3,4,5,6,7] and exposure to prenatal infection has been recently linked to specific neuropathological changes in schizophrenia [8]. Considering the known impact of prenatal infection on schizophrenia risk, the specificity of ventriculomegaly to the clinical illness and the suggested environmental influences on ventricular enlargement in this disorder, maternal infection during pregnancy may represent a significant environmental risk factor of ventricular enlargement in the offspring. Examination of prenatal immune activation effects on ventricular abnormalities and associated schizophrenia-related dysfunctions in adult life is clearly warranted

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call